Inflammation Stocks List Ranked for 2024 | NYSE,

Symbol	Grade	Name	% Change
MLTX	C	MoonLake Immunotherapeutics	1.77
OCUL	C	Ocular Therapeutix, Inc.	-2.51
KALA	C	Kala Pharmaceuticals, Inc.	-1.79
IMMX	C	Immix Biopharma, Inc.	-2.75
ALLK	D	Allakos Inc.	-4.02
ROIV	D	Roivant Sciences Ltd.	3.79
SEPN	D	Septerna, Inc.	0.02
NVO	D	Novo Nordisk A/S	-2.99
EYPT	D	EyePoint Pharmaceuticals, Inc.	-5.19
AMGN	D	Amgen Inc.	-0.05

Symbol	Grade	Name	Weight
BBH	D	Market Vectors Biotech ETF	17.74
IHI	A	iShares U.S. Medical Devices ETF	16.82
IBBQ	D	Invesco Nasdaq Biotechnology ETF	14.02
CANC	D	Tema Oncology ETF	13.78
IBB	D	iShares Nasdaq Biotechnology Index Fund	11.7

Compare ETFs

Compare BBH to IBB Compare IBBQ to IBB Compare IHI to IBB

Date	Stock	Title
Nov 21	MLTX	MoonLake Immunotherapeutics: A Somewhat Complicated Story
Nov 21	AMGN	Analysis-Wall Street awaits Amgen weight-loss drug data expected to move shares
Nov 21	AMGN	Amgen picks prolific biotech founder Chang as new top scientist
Nov 21	AMGN	Eli Lilly and 2 More Drug Stocks to Buy After RFK-Inspired Drop
Nov 20	AMGN	AMGEN ANNOUNCES SENIOR EXECUTIVE RESEARCH APPOINTMENT
Nov 20	NVO	More companies covering weight loss drugs for their employees
Nov 20	NVO	Weight loss drug makers want more insurance plans to cover Wegovy and Zepbound
Nov 20	AMGN	SLN Stock Down Despite Cholesterol Drug Lowering Lipoprotein Levels
Nov 20	SEPN	Septerna Reports Third Quarter 2024 Financial Results and Recent Business Highlights
Nov 20	NVO	Is Novo Nordisk Stock a Buy Right Now?
Nov 20	SEPN	Septerna initiated with an Overweight at JPMorgan
Nov 20	NVO	RFK Jr. Sparks New Worries About Obesity Drugs. Here’s What Investors Should Focus on Instead.
Nov 19	NVO	Novo Nordisk semaglutide phase 3 trial for MASH meets primary endpoints
Nov 19	NVO	Sector Update: Health Care Stocks Decline
Nov 19	AMGN	Amgen Stock Has High Implied Volatility. An Iron Condor Takes Advantage.
Nov 19	NVO	Novo Nordisk Unusual Options Activity For November 19
Nov 19	AMGN	Silence Therapeutics' Zerlasiran Has Competitive Concerns: Analyst
Nov 19	SEPN	Septerna started by J.P. Morgan at overweight, GPCR platform cited
Nov 19	NVO	Sector Update: Health Care Stocks Mixed Tuesday Afternoon
Nov 19	NVO	Novo Erases 2024 Gain, Wiping Out $210 Billion in Value

Inflammation: Inflammation is part of the complex biological response of body tissues to harmful stimuli, such as pathogens, damaged cells, or irritants, and is a protective response involving immune cells, blood vessels, and molecular mediators. The function of inflammation is to eliminate the initial cause of cell injury, clear out necrotic cells and tissues damaged from the original insult and the inflammatory process, and initiate tissue repair.